References
- Wang F, Shen L, Li J, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun. 2019;39(1):10–41. doi:10.1186/s40880-019-0349-9
- McCall MD, Graham PJ, Bathe OF. Quality of life: a critical outcome for all surgical treatments of gastric cancer. World J Gastroenterol. 2016;22(3):1101–1113. doi:10.3748/wjg.v22.i3.1101
- Jian W, Jia Z, Jun L, et al. High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial-mesenchymal transition in gastric cancer. Onco Targets Ther. 2016;9:3975–3983. doi:10.2147/OTT.S103112
- Purohit V, Simeone DM, Lyssiotis CA. Metabolic regulation of redox balance in cancer. Cancers. 2019;11(7):955–979. doi:10.3390/cancers11070955
- Huang M, Zhang L, Ding J, et al. Anticancer drug discovery from Chinese medicinal herbs. Chin Med. 2018;13(1):35–44. doi:10.1186/s13020-018-0192-y
- Yang H, Villani RM, Wang H, et al. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37(1):266–276. doi:10.1186/s13046-018-0909-x
- Jalmi SK, Sinha AK. ROS mediated MAPK signaling in abiotic and biotic stress-striking similarities and differences. Front Plant Sci. 2015;6:769–778. doi:10.3389/fpls.2015.00769
- Keuss MJ, Hjerpe R, Hsia O, et al. Unanchored tri-NEDD8 inhibits PARP-1 to protect from oxidative stress-induced cell death. EMBO J. 2019;38(6):e100024. doi:10.15252/embj.2018100024
- Huang Z, Liu CA, Cai PZ, et al. Omega-3PUFA attenuates MNU-induced colorectal cancer in rats by blocking PI3K/AKT/BCL-2 signaling. Onco Targets Ther. 2020;13:1953–1965. doi:10.2147/OTT.S241298
- Zhang XC. Effects of polydatin on the proliferation, migration, and invasion of ovarian cancer. BIOCELL. 2019;43(4):313–319. doi:10.32604/biocell.2019.07973
- Alhoshani A, Alatawi FO, Al-Anazi FE, et al. BCL-2 inhibitor venetoclax induces autophagy-associated cell death, cell cycle arrest, and apoptosis in human breast cancer cells. Onco Targets Ther. 2020;13:13357–13370. doi:10.2147/OTT.S281519
- Julien O, Wells JA. Caspases and their substrates. Cell Death Differ. 2017;24(8):1380–1389. doi:10.1038/cdd.2017.44
- Liu Y, Xie X, Wang W, et al. A randomized controlled trial for the effect of Modified Shenling Baizhu Powder on delaying the illness progress of COPD stable phase patients (GOLD 1-2 stages): a study protocol. Medicine. 2020;99(43):e22700. doi:10.1097/MD.0000000000022700
- Lu Y, Yang J, Wang X, et al. Research progress in use of traditional Chinese medicine for treatment of spinal cord injury. Biomed Pharmacother. 2020;127:110136. doi:10.1016/j.biopha.2020.110136
- Wu SY, Wang WJ, Dou JH, et al. Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury. Acta Pharmacol Sin. 2020;42:18–26. doi:10.1038/s41401-020-0383-9
- Jiang Y, Sun W, Li W, et al. Calycosin-7-O-β-D-glucoside promotes oxidative stress-induced cytoskeleton reorganization through integrin-linked kinase signaling pathway in vascular endothelial cells. BMC Complement Altern Med. 2015;15(1):315–326. doi:10.1186/s12906-015-0839-5
- Zhou R, Chen H, Chen J, et al. Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway. BMC Complement Altern Med. 2018;18(1):83–91. doi:10.1186/s12906-018-2148-2
- Liu M, Li P, Zeng X, et al. Identification and pharmacokinetics of multiple potential bioactive constituents after oral administration of radix astragali on cyclophosphamide-Induced Immunosuppression in Balb/c Mice. Int J Mol Sci. 2015;16(3):5047–5071. doi:10.3390/ijms16035047
- Chan SL, Ang X, Sani LL, et al. Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study. Br J Clin Pharmacol. 2016;82(6):1636–1646. doi:10.1111/bcp.13081
- Sun H, Yin M, Qian W, et al. Calycosin a PHYTOESTROGEN ISOflAVONE INDUCES APOPTOSIS OF ESTROGEN RECEPTOR-POSITIve MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Medical Science Monitor. 2018;24(5):6178–6186. doi:10.12659/MSM.910201
- Yang M, Liu B, Jin L, et al. Estrogen receptor β exhibited anti-tumor effects on osteosarcoma cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal pathway. J Bone Oncol. 2017;9:15–20. doi:10.1016/j.jbo.2017.09.005
- Nichani K, Li J, Suzuki M, et al. Evaluation of caspase-3 activity during apoptosis with fluorescence lifetime-based cytometry measurements and phasor analyses. Cytometry Part A. 2020;97(12):1265–1275. doi:10.1002/cyto.a.24207
- Kamil A, Khan MA, Aasim M, et al. Detection of ROS and translocation of ERP-57 in apoptotic induced human neuroblastoma (SH-SY5Y) cells. BIOCELL. 2019;43(3):167–174.
- Chertkova RV, Brazhe NA, Bryantseva TV, et al. New insight into the mechanism of mitochondrial Cytochrome C function. PLoS One. 2017;12(5):e0178280. doi:10.1371/journal.pone.0178280
- Nie XH, Ouyang J, Xing Y, et al. Calycosin inhibits migration and invasion through modulation of transforming growth factor beta-mediated mesenchymal properties in U87 and U251 cells. Drug Des Devel Ther. 2016;10:767–779.
- Wang Y, Xia CH, Lun ZQ, et al. Crosstalk between p38 MAPK and caspase-9 regulates mitochondria-mediated apoptosis induced by tetra-α-(4-carboxyphenoxy) phthalocyanine zinc photodynamic therapy in LoVo cells. Oncol Rep. 2018;39:61–70. doi:10.3892/or.2017.6071
- Qin X, Yuan LQ, Ruan HX, et al. Interaction of IL-22/IL-22R1 promotes cell proliferation and suppresses apoptosis of colorectal cancer via phosphorylation of STAT3. BIOCELL. 2019;43(2):89–98.
- Gilles C, Marie Odile F. The many roles of ubiquitin in NF-κB signaling. Biomedicines. 2018;6(2):43–89. doi:10.3390/biomedicines6020043
- Ren M, Wang X, Du G, et al. Calycosin-7-O-β-d-glucoside attenuates ischemia-reperfusion injury in vivo via activation of the PI3K/Akt pathway. Mol Med Rep. 2016;13(1):633–640. doi:10.3892/mmr.2015.4611
- Cheng XD, Gu JF, Yuan JR, et al. Suppression of A549 cell proliferation and metastasis by Calycosin via inhibition of the PKC-/ERK1/2 pathway: an in vitro investigation. Mol Med Rep. 2015;12(6):7992–8002. doi:10.3892/mmr.2015.4449
- Xia B, Wang J. Effects of adenosine on apoptosis of ovarian cancer A2780 cells via ROS and caspase pathways. Onco Targets Ther. 2019;12:9473–9480. doi:10.2147/OTT.S216620
- Hiroyasu I, Tatsuya A, Mitsuru S. Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model. Oncotarget. 2015;6(39):41863–41874. doi:10.18632/oncotarget.6172
- Sergio DM, Tanea TR, Paola V. et al. Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxid Med Cell Longev;2016. 1245049–1245093. doi:10.1155/2016/1245049
- Quan GH, Wang H, Cao J, et al. Calycosin Suppresses RANKL-mediated osteoclastogenesis through inhibition of MAPKs and NF-κB. Int J Mol Sci. 2015;16(12):29496–29507. doi:10.3390/ijms161226179
- Zerjatke T, Gak IA, Kirova D, et al. Quantitative cell cycle analysis based on an endogenous all-in-one reporter for cell tracking and classification. Cell Rep. 2017;19(9):1953–1966. doi:10.1016/j.celrep.2017.05.022
- Xie Y, Li F, Li Z, et al. miR-135a suppresses migration of gastric cancer cells by targeting TRAF5-mediated NF-κB activation. Onco Targets Ther. 2019;12:975–984. doi:10.2147/OTT.S189976
- Örd M, Venta R, Möll K, et al. Cyclin-specific docking mechanisms reveal the complexity of M-CDK function in the cell cycle. Mol Cell. 2019;75(1):76–89. doi:10.1016/j.molcel.2019.04.026
- Guo C, Ma Y, Ma S, et al. The role of TRPC6 in the neuroprotection of calycosin against cerebral ischemic injury. Sci Rep. 2017;7(1):3039–3052. doi:10.1038/s41598-017-03404-6
- Liu C, Zheng P, Liu X, et al. Calycosin attenuates TNBS-induced colitis through inibiting inflammatory cytokine and oxidative stress. Int J Clin Exp Med. 2017;10(11):15094–15105.